Brief: Annexin Pharmaceuticals appoints Jamal El-Mosleh new CEO
Oct 11 (Reuters) - ANNEXIN PHARMACEUTICALS AB (PUBL)
ANNX.ST :
* JAMAL EL-MOSLEH IS APPOINTED NEW CEO OF ANNEXIN
PHARMACEUTICALS AB
* JAMAL EL-MOSLEH STARTS AS CEO ON 16 OCTOBER 2017
Source text for Eikon: ID:nWkr6NLV8R
Further company coverage: ANNX.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Annexin Pharmaceuticals AB (publ)
See all newsBrief: Annexin Pharmaceuticals Q3 Net Loss At SEK 9.5 Mln
Brief: Annexin Pharmaceuticals Q2 2026 Net Loss SEK 11.6 Mln
Brief: Annexin Pharmaceuticals Gets International Nonproprietary Name Drug Candidate Anxv
Brief: Annexin Pharmaceuticals Updates On Nine Patients Treated In Nexus Study
Brief: Annexin's Rights Issue 98% Subscribed